Inhalation Sciences Sweden AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was SEK 1.295 million compared to SEK 2.442 million a year ago. Operating loss was SEK 5.506 million compared to SEK 3.823 million a year ago. Net loss was SEK 5.585 million compared to net income of SEK 16.541 million a year ago. Basic loss per share from continuing operations was SEK 0.56 compared to basic earnings per share from continuing operations of SEK 1.92 a year ago. Diluted loss per share from continuing operations was SEK 0.5 compared to diluted earnings per share from continuing operations of SEK 1.92 a year ago. For the half year, sales was SEK 4.134 million compared to SEK 8.196 million a year ago. Operating loss was SEK 9.070 million compared to SEK 2.608 million a year ago. Net loss was SEK 9.037 million compared to net income of SEK 17.196 million a year ago. Basic loss per share from continuing operations was SEK 0.91 compared to basic earnings per share from continuing operations of SEK 1.99 a year ago. Diluted loss per share from continuing operations was SEK 0.81 compared to diluted earnings per share from continuing operations of SEK 1.98 a year ago.